Doximity (NASDAQ:DOCS) Given New $70.00 Price Target at KeyCorp

Doximity (NASDAQ:DOCS) had its price target lowered by equities research analysts at KeyCorp from $83.00 to $70.00 in a report released on Wednesday, MarketBeat reports. The firm currently has an “overweight” rating on the stock. KeyCorp’s target price indicates a potential upside of 31.82% from the company’s current price.

DOCS has been the topic of several other reports. Leerink Partnrs raised shares of Doximity from a “hold” rating to a “strong-buy” rating in a research report on Friday, February 7th. Stephens initiated coverage on Doximity in a research report on Friday, December 20th. They issued an “equal weight” rating and a $55.00 price objective on the stock. The Goldman Sachs Group lifted their target price on Doximity from $58.00 to $80.00 and gave the stock a “neutral” rating in a report on Monday, February 10th. Piper Sandler raised Doximity from a “neutral” rating to an “overweight” rating and increased their price objective for the company from $31.00 to $78.00 in a research report on Friday, February 7th. Finally, Truist Financial decreased their target price on Doximity from $65.00 to $58.00 and set a “hold” rating for the company in a research report on Thursday, April 10th. Eleven equities research analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $65.00.

Doximity Trading Up 0.6 %

Doximity stock opened at $53.10 on Wednesday. Doximity has a 12 month low of $22.96 and a 12 month high of $85.21. The company has a market capitalization of $9.91 billion, a price-to-earnings ratio of 53.10, a price-to-earnings-growth ratio of 4.10 and a beta of 1.41. The business’s fifty day simple moving average is $63.40 and its two-hundred day simple moving average is $55.67.

Insider Activity

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of the firm’s stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the sale, the director now owns 6,360 shares in the company, valued at approximately $366,463.20. This trade represents a 75.87 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 37.40% of the company’s stock.

Institutional Trading of Doximity

Institutional investors and hedge funds have recently modified their holdings of the company. Global Retirement Partners LLC increased its stake in Doximity by 468.1% in the 4th quarter. Global Retirement Partners LLC now owns 534 shares of the company’s stock worth $29,000 after buying an additional 440 shares in the last quarter. UMB Bank n.a. raised its stake in Doximity by 69.1% during the 4th quarter. UMB Bank n.a. now owns 575 shares of the company’s stock valued at $31,000 after purchasing an additional 235 shares during the period. Larson Financial Group LLC lifted its holdings in Doximity by 49.4% in the 4th quarter. Larson Financial Group LLC now owns 756 shares of the company’s stock worth $40,000 after purchasing an additional 250 shares in the last quarter. Optimum Investment Advisors bought a new position in Doximity in the 4th quarter worth approximately $43,000. Finally, Morse Asset Management Inc purchased a new stake in Doximity during the 3rd quarter valued at approximately $46,000. 87.19% of the stock is currently owned by institutional investors.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.